PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTeriparatide acetate
Teriparatide acetate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
177 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteoporosisD010024EFO_0003882M81.0728172627102
Postmenopausal osteoporosisD015663EFO_0003854—54916740
Metabolic bone diseasesD001851——1724317
Bone fracturesD050723EFO_0003931T14.81533313
Spinal fracturesD016103EFO_0003902S12——1135
Stress fracturesD015775—M84.3——2114
Spinal cord injuriesD013119EFO_1001919——3—1—4
Chronic kidney disease-mineral and bone disorderD012080EFO_1001152N25.0——1113
Osteogenesis imperfectaD010013—Q78.0—1—2—3
Wounds and injuriesD014947—T14.8—2—1—3
Show 13 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypoparathyroidismD007011—E20152—17
Hip fracturesD006620EFO_0003964S72.00—21—25
HypocalcemiaD006996HP_0002901E83.51—21——3
Secondary hyperparathyroidismD006962EFO_1001173———1—12
AnorexiaD000855—R63.0—11——2
Anorexia nervosaD000856EFO_0004215F50.0—11——2
Femoral neck fracturesD005265EFO_1001792S72.00——2——2
Cerebrotendinous xanthomatosisD019294————1——1
DialysisD003956————1——1
Motor activityD009043EFO_0003940———1——1
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Osteoporotic fracturesD058866———3——47
Knee osteoarthritisD020370EFO_0004616M17—2——13
Bone diseasesD001847—M89.9—2——13
Colles' fractureD003100—S52.53—2———2
Myeloid leukemia acuteD015470—C92.0—1———1
Primary myelofibrosisD055728—D47.4—1———1
LymphomaD008223—C85.9—1———1
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.0—1———1
B-cell chronic lymphocytic leukemiaD015451—C91.1—1———1
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340——1———1
Show 17 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———4————4
PeriodontitisD010518EFO_0000649K05.31————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic kidney failureD007676EFO_0003884N18.6————11
OsteoarthritisD010003EFO_0002506M15-M19————11
OsteonecrosisD010020EFO_0004259M87————11
Bisphosphonate-associated osteonecrosis of the jawD059266——————11
Spontaneous fracturesD005598—M84.4————11
Vitamin d deficiencyD014808EFO_0003762E55————11
HyperparathyroidismD006961EFO_0008506E21.3————11
OsteomalaciaD010018EFO_1002027M83————11
MortalityD009026EFO_0004352—————11
Drug therapyD004358——————11
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
43 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use